Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $5.07B.
ENTERPRISE VALUE (EV)
$5.07B
Erasca, Inc.
Market Cap
$5.14B
Enterprise Value (EV)
$5.07B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Erasca, Inc. (ERAS) | $5.14B | $5.07B |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.08B | $5.45B |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.23B | $4.99B |
| Cogent Biosciences, Inc. (COGT)vs › | $5.28B | $5.35B |
| CRISPR Therapeutics AG (CRSP)vs › | $5.29B | $5.78B |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.91B | $5.34B |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.89B | $4.63B |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.86B | $4.75B |
| Doximity, Inc. (DOCS)vs › | $5.36B | $5.10B |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.44B | $5.08B |
Market Cap
$5.14B
Total Debt
$0.00
Cash
$73.81M
Enterprise Value
$5.07B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
